Fig. 1From: A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancerA 75-year-old patient with breast cancer with a single brain metastasis had a partial response after 3 BEEP regimen cycles. T1-weighted image (T1WI) and DCE-MRI parameter maps (Peak, Slope, iAUC60, and Ktrans) of the metastatic tumor in the right frontal lobe at baseline, 1Â h, 24Â h, and 21Â days after the first cycle of BEEP regimen, respectivelyBack to article page